Industry News
Biotechnology Industry News

Synairgen’s pivotal COVID-19 SPRINTER trial falls at final hurdle, sending stock into downward spiral
Synairgen's pivotal COVID-19 SPRINTER trial falls at final hurdle, sending stock into downward spiral ntaylor Tue, 02/22/2022 - 04:49
Atara, Memorial Sloan Kettering investigating patient death in phase 1 mesothelioma CAR-T study
Atara, Memorial Sloan Kettering investigating patient death in phase 1 mesothelioma CAR-T study klahucik Fri, 02/18/2022 - 13:05
Ribon taps former Novartis VP, Flagship partner Raman as CEO
Ribon taps former Novartis VP, Flagship partner Raman as CEO mbayer Fri, 02/18/2022 - 10:19
Ligand to spin off J&J-partnered antibody unit with $70M in funding
Ligand to spin off J&J-partnered antibody unit with $70M in funding klahucik Fri, 02/18/2022 - 09:35
FDA grounds BioMarin gene therapy trial for months with demand for tumor risk data
FDA grounds BioMarin gene therapy trial for months with demand for tumor risk data ntaylor Fri, 02/18/2022 - 06:13
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal ntaylor Fri, 02/18/2022 - 05:04
‘Early stage’: Majority of biotechs don’t disclose ESG practices, but most plan to in near term
'Early stage': Majority of biotechs don't disclose ESG practices, but most plan to in near term klahucik Thu, 02/17/2022 - 11:23
After clinical hold, Yumanity to cut 60% of workforce by April and hunt for a buyer
After clinical hold, Yumanity to cut 60% of workforce by April and hunt for a buyer mbayer Thu, 02/17/2022 - 10:56
Recommended Strategies for Your Next Biomarker-Driven Clinical Trial
Recommended Strategies for Your Next Biomarker-Driven Clinical Trial mwen Thu, 02/17/2022 - 09:40
Ex-NIH chief Collins returns as science adviser to Biden weeks into retirement
Ex-NIH chief Collins returns as science adviser to Biden weeks into retirement klahucik Thu, 02/17/2022 - 09:35
Innovent’s phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market
Innovent's phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market ntaylor Thu, 02/17/2022 - 09:14
Billionaire’s fund backs Heidelberg to carve out niche in busy BCMA space
Billionaire's fund backs Heidelberg to carve out niche in busy BCMA space ntaylor Thu, 02/17/2022 - 07:56
Remix Therapeutics signs Janssen licensing deal that could top $1B
Remix Therapeutics signs Janssen licensing deal that could top $1B mbayer Wed, 02/16/2022 - 18:00
Chutes & Ladders—Califf returns to FDA after narrow Senate confirmation
Chutes & Ladders—Califf returns to FDA after narrow Senate confirmation klahucik Wed, 02/16/2022 - 14:14
NIAID vaccine R&D director who collaborated with Moderna on COVID-19 vaccine to retire
NIAID vaccine R&D director who collaborated with Moderna on COVID-19 vaccine to retire mbayer Wed, 02/16/2022 - 12:43
Gilead comes back around on Hookipa HIV partnership, signing away $15M upfront and more down the line
Gilead comes back around on Hookipa HIV partnership, signing away $15M upfront and more down the line klahucik Wed, 02/16/2022 - 09:49
Sage, Biogen score on phase 3 depression trial, but we still don’t know about durability
Sage, Biogen score on phase 3 depression trial, but we still don't know about durability aarmstrong Wed, 02/16/2022 - 09:27
Mirati’s ‘very big’ KRAS drug gets December decision date, further extending Lumakras’ first-mover status
Mirati's 'very big' KRAS drug gets December decision date, further extending Lumakras' first-mover status klahucik Wed, 02/16/2022 - 08:52
After a year as Merck KGaA healthcare CEO, Guenter reflects on I-O bispecific flop, spots new multiple sclerosis strategy
After a year as Merck KGaA healthcare CEO, Guenter reflects on I-O bispecific flop, spots new multiple sclerosis strategy aliu Wed, 02/16/2022 - 06:03
Third Harmonic Bio raises $105M in series B to push hives treatment through phase 1b
Third Harmonic Bio raises $105M in series B to push hives treatment through phase 1b mbayer Tue, 02/15/2022 - 16:24

